Xeris Biopharma Holdings, Inc. (XERS)
NASDAQ: XERS · Real-Time Price · USD
7.93
-0.20 (-2.46%)
At close: Jan 9, 2026, 4:00 PM EST
8.00
+0.07 (0.88%)
After-hours: Jan 9, 2026, 7:14 PM EST
Xeris Biopharma Holdings Market Cap
Xeris Biopharma Holdings has a market cap or net worth of $1.32 billion as of January 9, 2026. Its market cap has increased by 152.89% in one year.
Market Cap
1.32B
Enterprise Value
1.48B
1-Year Change
152.89%
Ranking
Category
Stock Price
$7.93
Market Cap Chart
Since October 6, 2021, Xeris Biopharma Holdings's market cap has increased from $295.78M to $1.32B, an increase of 344.86%. That is a compound annual growth rate of 41.96%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 8, 2026 | 1.35B | 3.57% |
| Dec 31, 2025 | 1.30B | 157.72% |
| Dec 31, 2024 | 505.39M | 55.70% |
| Dec 29, 2023 | 324.59M | 79.47% |
| Dec 30, 2022 | 180.86M | -50.50% |
| Dec 31, 2021 | 365.40M | 23.54% |
| Oct 6, 2021 | 295.78M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 971.66B |
| Johnson & Johnson | 495.71B |
| AbbVie | 396.12B |
| UnitedHealth Group | 314.19B |
| AstraZeneca | 295.31B |
| Merck & Co. | 275.48B |
| Novartis AG | 273.11B |
| Novo Nordisk | 256.73B |